pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 12·1 min read
save

Biopharma exec pay reveals quirky perks like private jets and wildfire relief grants

Jun 12, 2026·read at Endpoints ↗Neutral

A recent review of thousands of biopharma C‑suite compensation packages found that most line items blend into the massive totals, but a few stand out for their unusual nature.

Among the highlighted perks were the use of private jets, a contribution to wildfire relief efforts, and an internet expense of $23,000, all noted in the 2025 pay disclosures.

These anomalies are rare, underscoring growing attention on how executive compensation is structured in the industry and prompting calls for greater transparency.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Biopharma's pay oddities of 2025: Executive perks and eccentricities”

read at Endpoints ↗
86 words · retrieved Jun 12
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.3
topics
Rare Disease3

related stories

  • Apr 28STAT+: AIDS group sues Trump administration over undisclosed agreement with GileadSTAT
  • Apr 28Opinion: Healthcare or health care? Help STAT decideSTAT
  • Apr 28Opinion: FDA commissioner: ‘Smarter,’ real-time clinical trials could transform drug developmentSTAT
  • Apr 28Pfizer deals extend patent life for a top-selling rare disease drugBioPharma Dive
  • Apr 28STAT+: Supreme Court to hear case about ‘skinny labeling’ and generic accessSTAT